Current advances in research and clinical applications of PLGA-based nanotechnology

Co-polymer poly(lactic-co-glycolic acid) (PLGA) nanotechnology has been developed for many years and has been approved by the US FDA for the use of drug delivery, diagnostics and other applications of clinical and basic science research, including cardiovascular disease, cancer, vaccine and tissue engineering. This article presents the more recent successes of applying PLGA-based nanotechnologies and tools in these medicine-related applications. It focuses on the possible mechanisms, diagnosis and treatment effects of PLGA preparations and devices. This updated information will benefit to both new and established research scientists and clinical physicians who are interested in the development and application of PLGA nanotechnology as new therapeutic and diagnostic strategies for many diseases.

[1]  R. Bordet,et al.  Fenofibrate-loaded PLGA microparticles: effects on ischemic stroke. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  J. Peters,et al.  Poly(I:C) coated PLGA microparticles induce dendritic cell maturation. , 2009, International journal of pharmaceutics.

[3]  Jong-sang Park,et al.  A Novel Technique for Loading of Paclitaxel‐PLGA Nanoparticles onto ePTFE Vascular Grafts , 2008, Biotechnology progress.

[4]  Z. Duan,et al.  Biodistribution and Pharmacokinetic Analysis of Paclitaxel and Ceramide Administered in Multifunctional Polymer-Blend Nanoparticles in Drug Resistant Breast Cancer Model , 2008, Molecular pharmaceutics.

[5]  M. Patarroyo,et al.  Gamma-irradiation effects on biopharmaceutical properties of PLGA microspheres loaded with SPf66 synthetic vaccine. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[6]  M. Saltzman,et al.  Biopolymer nanoparticles as antigen delivery vehicles for immunotherapy of head and neck squamous cell carcinoma (HNSCC) , 2008 .

[7]  Ali Khademhosseini,et al.  Microfluidic chip-based fabrication of PLGA microfiber scaffolds for tissue engineering. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[8]  V. Labhasetwar,et al.  Superoxide Dismutase-Loaded PLGA Nanoparticles Protect Cultured Human Neurons Under Oxidative Stress , 2008, Applied biochemistry and biotechnology.

[9]  Dar-Bin Shieh,et al.  Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes. , 2008, Biomaterials.

[10]  Tejraj M Aminabhavi,et al.  Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[11]  T. Desai,et al.  Purified and surfactant-free coenzyme Q10-loaded biodegradable nanoparticles. , 2008, International journal of pharmaceutics.

[12]  Manmohan J. Singh,et al.  A comparison of anionic nanoparticles and microparticles as vaccine delivery systems , 2008, Human vaccines.

[13]  M A Vandelli,et al.  Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Vishwanatha Somayaji,et al.  Pharmaceutical analysis of synthetic lipid A-based vaccine adjuvants in poly (D,L-lactic-co-glycolic acid) nanoparticle formulations. , 2007, Journal of pharmaceutical and biomedical analysis.

[15]  Shenmin Zhang,et al.  Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels , 2007, Journal of materials science. Materials in medicine.

[16]  D. Busch,et al.  Antigen co‐encapsulated with adjuvants efficiently drive protective T cell immunity , 2007, European journal of immunology.

[17]  M. Hatziapostolou,et al.  Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[18]  Y. Schneider,et al.  PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Janko Kos,et al.  Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Michihiro Nakamura,et al.  Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles , 2007, International journal of cancer.

[21]  S. Pan,et al.  Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment. , 2007, Nanomedicine.

[22]  A. Alshamsan,et al.  Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles. , 2007, Journal of biomedical materials research. Part A.

[23]  Thomas Kissel,et al.  Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[24]  V. Torchilin.  Targeted pharmaceutical nanocarriers for cancer therapy and imaging , 2007, The AAPS Journal.

[25]  Xiaoming Yang.  Nano- and microparticle-based imaging of cardiovascular interventions: overview. , 2007, Radiology.

[26]  S. Hamdy,et al.  “Pathogen-Mimicking” Nanoparticles for Vaccine Delivery to Dendritic Cells , 2007, Journal of immunotherapy.

[27]  S. Bailey,et al.  Nanotechnology in cardiovascular medicine , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[28]  S. Caruthers,et al.  Molecular imaging and therapy of atherosclerosis with targeted nanoparticles , 2007, Journal of magnetic resonance imaging : JMRI.

[29]  Hongfan Sun,et al.  Modified Paclitaxel-loaded Nanoparticles for Inhibition of Hyperplasia in a Rabbit Arterial Balloon Injury Model , 2007, Pharmaceutical Research.

[30]  Peter Lin,et al.  Development of Small-Diameter Vascular Grafts , 2007, World Journal of Surgery.

[31]  A. Florence,et al.  PLGA-dendron nanoparticles enhance immunogenicity but not lethal antibody production of a DNA vaccine against anthrax in mice. , 2007, International journal of pharmaceutics.

[32]  Dongmei Cun,et al.  Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery. , 2007, Journal of pharmaceutical sciences.

[33]  Robert Langer,et al.  Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. , 2007, Biomaterials.

[34]  Kapil Khatri,et al.  M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B , 2007, Journal of drug targeting.

[35]  R. Gurny,et al.  Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer. , 2006, International journal of pharmaceutics.

[36]  Flemming Forsberg,et al.  Comparison of in vitro and in vivo acoustic response of a novel 50:50 PLGA contrast agent. , 2006, Ultrasonics.

[37]  Marianne J. Ellis,et al.  Effects of common sterilization methods on the structure and properties of poly(D,L lactic-co-glycolic acid) scaffolds. , 2006, Tissue engineering.

[38]  Jong-sang Park,et al.  Paclitaxel-coated expanded polytetrafluoroethylene haemodialysis grafts inhibit neointimal hyperplasia in porcine model of graft stenosis. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  Sumona Sarkar,et al.  Development and characterization of a porous micro-patterned scaffold for vascular tissue engineering applications. , 2006, Biomaterials.

[40]  Y. Kawashima,et al.  Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[41]  L. Kwak,et al.  Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[42]  P. Diwan,et al.  Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles. , 2006, Die Pharmazie.

[43]  J. Benoit,et al.  Development and characterization of interleukin-18-loaded biodegradable microspheres. , 2006, International journal of pharmaceutics.

[44]  A. Cheung,et al.  Development of a sustained-release system for perivascular delivery of dipyridamole. , 2006, Journal of biomedical materials research. Part B, Applied biomaterials.

[45]  B. Gander,et al.  Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells. , 2006, Vaccine.

[46]  Vishal Saxena,et al.  Polymeric nanoparticulate delivery system for Indocyanine green: biodistribution in healthy mice. , 2006, International journal of pharmaceutics.

[47]  C. Astete,et al.  Synthesis and characterization of PLGA nanoparticles , 2006, Journal of biomaterials science. Polymer edition.

[48]  Patrick Winter,et al.  Applications of Nanotechnology to Atherosclerosis, Thrombosis, and Vascular Biology , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[49]  L. Lim,et al.  Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[50]  J. Ito,et al.  Drug Delivery to the Cochlea Using PLGA Nanoparticles , 2005, The Laryngoscope.

[51]  Craig J. Hawker,et al.  The Convergence of Synthetic Organic and Polymer Chemistries , 2005, Science.

[52]  P. Opolon,et al.  In Vitro Echogenicity Characterization of Poly[lactide-coglycolide] (PLGA) Microparticles and Preliminary In Vivo Ultrasound Enhancement Study for Ultrasound Contrast Agent Application , 2005, Investigative radiology.

[53]  Alexander M Seifalian,et al.  Current status of prosthetic bypass grafts: a review. , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.

[54]  Julie H. Campbell,et al.  Tissue-Engineered Blood Vessels: Alternative to Autologous Grafts? , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[55]  M. Briel,et al.  Effect of different antilipidemic agents and diets on mortality: a systematic review. , 2005, Archives of internal medicine.

[56]  Xiao Zhou,et al.  Preparation and evaluation of poly(L-lactide-co-glycolide) (PLGA) microbubbles as a contrast agent for myocardial contrast echocardiography. , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.

[57]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  Seung‐Woo Cho,et al.  Small-Diameter Blood Vessels Engineered With Bone Marrow–Derived Cells , 2005, Annals of surgery.

[59]  T. Ishihara,et al.  Treatment of experimental arthritis with poly(d, l-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate , 2005, Annals of the rheumatic diseases.

[60]  Christopher Breuer,et al.  Artificial blood vessel: the Holy Grail of peripheral vascular surgery. , 2005, Journal of vascular surgery.

[61]  George M Whitesides,et al.  Nanoscience, nanotechnology, and chemistry. , 2005, Small.

[62]  R. Carroll,et al.  Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[63]  O. Franco,et al.  The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75% , 2004, BMJ : British Medical Journal.

[64]  V. Fuster,et al.  Technology Insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging , 2004, Nature Clinical Practice Cardiovascular Medicine.

[65]  G. Golomb,et al.  Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries. , 2004, Cardiovascular research.

[66]  K. Avgoustakis,et al.  Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery. , 2004, Current drug delivery.

[67]  A Anon,et al.  Nanomedicine -- a tremendous research opportunity for analytical chemists. , 2004, The Analyst.

[68]  M. Dake,et al.  Stent-based controlled release of intravascular angiostatin to limit plaque progression and in-stent restenosis. , 2004, Journal of vascular and interventional radiology : JVIR.

[69]  J. H. van Bockel,et al.  Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. , 2004, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[70]  M. Wheatley,et al.  Polymeric contrast agent with targeting potential. , 2004, Ultrasonics.

[71]  B. Ludewig,et al.  Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy. , 2004, Journal of immunological methods.

[72]  V. Labhasetwar,et al.  Critical Determinants in PLGA/PLA Nanoparticle-Mediated Gene Expression , 2004, Pharmaceutical Research.

[73]  S. Sahoo,et al.  Nanotech approaches to drug delivery and imaging. , 2003, Drug discovery today.

[74]  Jayanth Panyam,et al.  Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[75]  D. McDonald,et al.  Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles. , 2003, Cellular immunology.

[76]  R. Levy,et al.  DNA delivery from an intravascular stent with a denatured collagen-polylactic-polyglycolic acid-controlled release coating: mechanisms of enhanced transfection , 2003, Gene Therapy.

[77]  K. Avgoustakis,et al.  Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles. , 2003, International journal of pharmaceutics.

[78]  Laura E Niklason,et al.  Human arteries engineered in vitro , 2003, EMBO reports.

[79]  B. Goldberg,et al.  Effect of shell type on the in vivo backscatter from polymer-encapsulated microbubbles. , 2003, Ultrasound in medicine & biology.

[80]  B. Gander,et al.  An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria. , 2003, Journal of pharmaceutical sciences.

[81]  B. Gander,et al.  Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro. , 2003, Vaccine.

[82]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[83]  Jayanth Panyam,et al.  Dynamics of Endocytosis and Exocytosis of Poly(D,L-Lactide-co-Glycolide) Nanoparticles in Vascular Smooth Muscle Cells , 2003, Pharmaceutical Research.

[84]  Takehisa Matsuda,et al.  Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing. , 2003, Tissue engineering.

[85]  G. Golomb,et al.  Novel PDGFβR antisense encapsulated in polymeric nanospheres for the treatment of restenosis , 2002, Gene Therapy.

[86]  S. Simões,et al.  Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[87]  N. Caplice,et al.  Smooth Muscle Progenitor Cells in Human Blood , 2002, Circulation.

[88]  B. Gander,et al.  On Technological and Immunological Benefits of Multivalent Single-Injection Microsphere Vaccines , 2002, Pharmaceutical Research.

[89]  Jayanth Panyam,et al.  Rapid endo‐lysosomal escape of poly(DL‐lactide‐coglycolide) nanoparticles: implications for drug and gene delivery , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[90]  Robert W. Thompson.  Reflections on the Pathogenesis of Abdominal Aortic Aneurysms , 2002, Cardiovascular surgery.

[91]  S. Sahoo,et al.  Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[92]  Jong-sang Park,et al.  Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance. , 2002, Arthritis and rheumatism.

[93]  V. Labhasetwar,et al.  Characterization of nanoparticle uptake by endothelial cells. , 2002, International journal of pharmaceutics.

[94]  A. Kabanov,et al.  Pluronic block copolymers: novel functional molecules for gene therapy. , 2002, Advanced drug delivery reviews.

[95]  A. Karydas,et al.  PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[96]  M. Khan,et al.  Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[97]  Alexander V Kabanov,et al.  Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. , 2002, Advanced drug delivery reviews.

[98]  K. Leong,et al.  The design of scaffolds for use in tissue engineering. Part I. Traditional factors. , 2001, Tissue engineering.

[99]  Y. Kawashima,et al.  Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. , 2001, The Journal of pharmacology and experimental therapeutics.

[100]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[101]  David J Brayden,et al.  Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells. , 2001, Vaccine.

[102]  A Giudiceandrea,et al.  The Mechanical Behavior of Vascular Grafts: A Review , 2001, Journal of biomaterials applications.

[103]  R. A. Jain,et al.  The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. , 2000, Biomaterials.

[104]  S. Hyon,et al.  Biodegradable poly (lactic acid) microspheres for drug delivery systems. , 2000, Yonsei medical journal.

[105]  R. Levy,et al.  Gene delivery from a DNA controlled-release stent in porcine coronary arteries , 2000, Nature Biotechnology.

[106]  Wim E. Hennink,et al.  Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles , 2000, Pharmaceutical Research.

[107]  J. Eyles,et al.  Protection studies following bronchopulmonary and intramuscular immunisation with yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy. , 2000, Vaccine.

[108]  D. Wise,et al.  Induction of secretory immunity with bioadhesive poly (D,L-lactide-co-glycolide) microparticles containing Streptococcus sobrinus glucosyltransferase. , 2000, Oral microbiology and immunology.

[109]  S. Kaul,et al.  Polymeric-based perivascular delivery of a nitric oxide donor inhibits intimal thickening after balloon denudation arterial injury: role of nuclear factor-kappaB. , 2000, Journal of the American College of Cardiology.

[110]  J. Eyles,et al.  Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[111]  Laura E. Niklason,et al.  Replacement Arteries Made to Order , 1999, Science.

[112]  R. Mecham,et al.  Characterization of an in vitro model of elastic fiber assembly. , 1999, Molecular biology of the cell.

[113]  G S Gazelle,et al.  Radio-frequency-induced coagulation necrosis in rabbits: immediate detection at US with a synthetic microsphere contrast agent. , 1999, Radiology.

[114]  A. Bozkır,et al.  Studies on the Co‐encapsulation, Release and Integrity of Two Subunit Antigens: rV and rF1 from Yersinia pestis , 1999, The Journal of pharmacy and pharmacology.

[115]  T. Lüscher,et al.  Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[116]  R Langer,et al.  Functional arteries grown in vitro. , 1999, Science.

[117]  S. W. Kim,et al.  Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheres. , 1998, Journal of biomedical materials research.

[118]  C. Rhodes,et al.  Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches. , 1998, Drug development and industrial pharmacy.

[119]  C. Bauters,et al.  Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis. , 1998, Circulation.

[120]  C Vigneron,et al.  Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[121]  M. Shive,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres , 1997 .

[122]  C Di Mario,et al.  Long-term clinical follow-up after successful repeat percutaneous intervention for stent restenosis. , 1997, Journal of the American College of Cardiology.

[123]  A. Mikos,et al.  Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles. , 1997, Journal of biomedical materials research.

[124]  B. McNeil,et al.  Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. , 1997, The New England journal of medicine.

[125]  K. Leong,et al.  Controlled delivery of antigens and adjuvants in vaccine development. , 1996, Journal of pharmaceutical sciences.

[126]  E J Topol,et al.  Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty. , 1996, Circulation.

[127]  S M Schwartz,et al.  The intima. Soil for atherosclerosis and restenosis. , 1995, Circulation research.

[128]  Jean-Christophe Olivier,et al.  Drug transport to brain with targeted nanoparticles , 2011, NeuroRX.

[129]  A. Ray,et al.  Formulation, characterization and evaluation of rotavirus encapsulated PLA and PLGA particles for oral vaccination. , 2009, Journal of microencapsulation.

[130]  Nicole M. Iverson,et al.  Convergence of nanotechnology and cardiovascular medicine : progress and emerging prospects. , 2008, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

[131]  T. Park,et al.  Direct plasmid DNA encapsulation within PLGA nanospheres by single oil-in-water emulsion method. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[132]  Jagdish Singh,et al.  Poly (lactide-co-glycolide)-Polymethacrylate Nanoparticles for Intramuscular Delivery of Plasmid Encoding Interleukin-10 to Prevent Autoimmune Diabetes in Mice , 2008, Pharmaceutical Research.

[133]  S. Mousa,et al.  Micro- and nanoparticle-based vaccines for hepatitis B. , 2007, Advances in experimental medicine and biology.

[134]  F. Söylemezoğlu,et al.  Treatment Of Malignant Gliomas With Mitoxantrone-Loaded Poly (Lactide-Co-Glycolide) Microspheres. , 2006, Neurosurgery.

[135]  D. Vorp,et al.  Molecular aspects of vascular tissue engineering. , 2005, Frontiers in bioscience : a journal and virtual library.

[136]  M. Bednarski,et al.  Vascular-targeted nanoparticles for molecular imaging and therapy. , 2004, Methods in enzymology.

[137]  L. Niklason.  Techview: medical technology. Replacement arteries made to order. , 1999, Science.

[138]  Anderson,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.

[139]  C. M. Agrawal,et al.  Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. , 1996, Biomaterials.

[140]  D. Wise,et al.  Poly(lactic/glycolic acid) biodegradable drug-polymer matrix systems. , 1985, Methods in enzymology.